Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2016

Patel KR, Phillips DJ, Leibowitz JM, Scognamiglio T, Banuchi VE, Kuhel WI, et al. Value within otolaryngology: Assessment of the cost-utility analysis literature. World J Otorhinolaryngol Head Neck Surg. 2016;2(1):28-37.

Nambiar L, Alex A, Siskind E, Shen AW, Fan C, Grimaldi G, et al. Type VI Choledochal Cyst-An Unusual Presentation of Jaundice. Int J Angiol. 2016;25(4):263-265.

Fontugne J, Davis K, Palanisamy N, Udager A, Mehra R, McDaniel AS, et al. Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry. Mod Pathol. 2016;29(2):157-65.

Cushing MM, Asmis L, Calabia C, Rand JH, Haas T. Efficacy of solvent/detergent plasma after storage at 2-8 °C for 5 days in comparison to other plasma products to improve factor V levels in factor V deficient plasma. Transfus Apher Sci. 2016;55(1):114-9.

Smith AL, Abdul-Karim FW, Goyal A. Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines. Cancer Cytopathol. 2016;124(4):285-93.

Pan J-, Sun Y, Jiang Y-, Bott AJ, Jaber N, Dou Z, et al. TRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis. Mol Cell. 2016;62(1):149-51.

Gutierrez C, Kebriaei P, Turner KA, Yemelyanova A, Ariza-Heredia EJ, Foo WC. A unique presentation of acute liver failure from herpes simplex virus hepatitis. Transpl Infect Dis. 2016;18(4):592-4.

Kelly RS, Sinnott JA, Rider JR, Ebot EM, Gerke T, Bowden M, et al. The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study. Cancer Metab. 2016;4:22.

Khani F, Robinson BD. A "Chicken or Egg" Conundrum: Race, Molecular Subtype, and Tumor Location in Prostate Cancer. Eur Urol. 2016;70(1):18-20.

Trasino SE, Tang X-, Jessurun J, Gudas LJ. A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease. J Mol Med (Berl). 2016;94(10):1143-1151.